Minimizing Hypoglycemia While Maintaining Glycemic Control in Diabetes
暂无分享,去创建一个
[1] S. Schinner,et al. Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .
[2] S. Schinner. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .
[3] P. Cryer. The Barrier of Hypoglycemia in Diabetes , 2008, Diabetes.
[4] A. Ertl,et al. Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals , 2008, Diabetes.
[5] Roman Hovorka,et al. The future of continuous glucose monitoring: closed loop. , 2008, Current diabetes reviews.
[6] L. Thabane,et al. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. , 2008, Diabetes research and clinical practice.
[7] Hui Tang,et al. Modafinil modulates GABA-activated currents in rat hippocampal pyramidal neurons , 2008, Brain Research.
[8] A. Berghold,et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis , 2008, Diabetologia.
[9] R. Gerard. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. , 2008 .
[10] G. Reach. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. , 2008, Diabetes technology & therapeutics.
[11] R. M. Meloche. Transplantation for the treatment of type 1 diabetes. , 2007, World journal of gastroenterology.
[12] I M E Wentholt,et al. Continuous glucose monitors: the long-awaited watch dogs? , 2007, Diabetes technology & therapeutics.
[13] G. Guyatt,et al. Patient-important outcomes in diabetes—time for consensus , 2007, The Lancet.
[14] A. Berghold,et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. , 2007, The Cochrane database of systematic reviews.
[15] R. Sherwin,et al. ATP-Sensitive K+ Channels Regulate the Release of GABA in the Ventromedial Hypothalamus During Hypoglycemia , 2007, Diabetes.
[16] E Renard,et al. Implantable insulin pumps. A position statement about their clinical use. , 2007, Diabetes & metabolism.
[17] P. Lucidi,et al. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia , 2007, Diabetologia.
[18] Philippe Morel,et al. International trial of the Edmonton protocol for islet transplantation. , 2006, The New England journal of medicine.
[19] P. Cryer,et al. Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. , 2006, The Journal of clinical endocrinology and metabolism.
[20] J. Pickup,et al. Are insulin pumps underutilized in type 1 diabetes? Yes. , 2006, Diabetes care.
[21] S. Heller,et al. Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[22] R. Sherwin,et al. Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. , 2005, Diabetes.
[23] I. Mühlhauser,et al. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study , 2005, Diabetologia.
[24] Jacqueline Ryder,et al. Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes. , 2005, Diabetes care.
[25] P. Cryer,et al. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. , 2005, Diabetes.
[26] T R Pieber,et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. , 2006, The Cochrane database of systematic reviews.
[27] I. Macdonald,et al. The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia , 2004, Diabetologia.
[28] R. Sherwin,et al. Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. , 2004, Diabetes.
[29] N. Waugh,et al. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. , 2004, Health technology assessment.
[30] J. Plank,et al. Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up , 2004, Diabetologia.
[31] S. Colagiuri,et al. Hypoglycaemia with insulin aspart: a double‐blind, randomised, crossover trial in subjects with Type 1 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[32] Bruce A Buckingham,et al. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. , 2004, The Journal of pediatrics.
[33] K. Hermansen,et al. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes , 2004, Diabetologia.
[34] I. Mühlhauser,et al. Patient education as the basis for diabetes care in clinical practice and research , 1985, Diabetologia.
[35] C. Tack,et al. Effect of 2 Weeks of Theophylline on Glucose Counterregulation in Patients with Type 1 Diabetes and Unawareness of Hypoglycemia , 2003, Clinical pharmacology and therapeutics.
[36] S. Amiel,et al. The effects of KATP channel modulators on counterregulatory responses and cognitive function during acute controlled hypoglycaemia in healthy men: a pilot study , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[37] I. Mühlhauser,et al. Patient education – evaluation of a complex intervention , 2002, Diabetologia.
[38] Aaron B. Neinstein,et al. Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. , 2002, The Journal of pediatrics.
[39] A. Moran,et al. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. , 2002, Diabetes care.
[40] J. Pasman,et al. Theophylline improves hypoglycemia unawareness in type 1 diabetes. , 2002, Diabetes.
[41] B. Zinman,et al. Insulins today and beyond , 2001, The Lancet.
[42] D. Cox,et al. Blood glucose awareness training (BGAT-2): long-term benefits. , 2001, Diabetes care.
[43] M. Lunt,et al. Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. , 2000, Diabetes care.
[44] M. Quigley,et al. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. , 1999, Diabetes care.
[45] P. Cryer,et al. Durable reversal of hypoglycemia unawareness in type 1 diabetes. , 1999, Diabetes care.
[46] F. Holleman,et al. Reduced Frequency of Severe Hypoglycemia and Coma in Well-Controlled IDDM Patients Treated With Insulin Lispro , 1997, Diabetes Care.
[47] P. Cryer,et al. Alanine and Terbutaline in the Prevention of Nocturnal Hypoglycemia in IDDM , 1997, Diabetes Care.
[48] I. Mühlhauser,et al. Intensified insulin therapy and the risk of severe hypoglycaemia , 1997, Diabetologia.
[49] D. Cox,et al. A Multicenter Evaluation of Blood Glucose Awareness Training-II , 1995, Diabetes Care.
[50] P. Cryer,et al. Reversal of Hypoglycemia Unawareness, But Not Defective Glucose Counterregulation, in IDDM , 1994, Diabetes.
[51] A. Maran,et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes , 1994, The Lancet.
[52] Paolo Brunetti,et al. Meticulous Prevention of Hypoglycemia Normalizes the Glycemic Thresholds and Magnitude of Most of Neuroendocrine Responses to, Symptoms of, and Cognitive Function During Hypoglycemia in Intensively Treated Patients With Short-Term IDDM , 1993, Diabetes.
[53] W. Tamborlane,et al. Effect of Caffeine on the Recognition of and Responses to Hypoglycemia in Humans , 1993, Annals of Internal Medicine.
[54] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[55] H. Imura,et al. Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. , 1993, The New England journal of medicine.
[56] P. Cryer,et al. Induction of Hypoglycemia Unawareness by Asymptomatic Nocturnal Hypoglycemia , 1993, Diabetes.
[57] I. Mühlhauser,et al. Diabetes education and insulin therapy: when will they ever learn? , 1993, Journal of internal medicine.
[58] J. Brange,et al. Monomeric insulins obtained by protein engineering and their medical implications , 1988, Nature.
[59] S. Colagiuri,et al. The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.